Clinical Trials · NCT03287076
Trial of EXenatide in Acute Ischaemic Stroke
- Phase
- Phase 2
- Recruitment status
- Unknown
- Sponsor
- Neuroscience Trials Australia
- Enrollment
- 350
- Start date
- Nov 2017
- Locations
- 15 sites, 3 countries
- Primary endpoint
- improved neurological outcome